Faculty profile

Alanah Bergman

Back to faculty

Honorary LecturerUBC Physics & AstronomyUniversity of British Columbia

Alanah Bergman

Honorary Lecturer

UBC Physics & Astronomy

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
16 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

326

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of British Columbia profile.

Latest papers

Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.
International journal of radiation oncology, biology, physics · 2026
The role of abdominal compression in the reduction of respiratory motion for cardiac radioablation.
Journal of applied clinical medical physics · 2026
Multi-lead Monitoring to Deduce Translations and Rotations of the Heart Through Respiration and Its Geometric Implications for Motion Management in Cardiac Radioablation.
International journal of radiation oncology, biology, physics · 2026

All 21 publications

Latest funding

Future of Stereotactic Ablative Radiotherapy (SABR) Trials in Oligometastatic Cancer: Continuing Canadian-Led International Investigations in Radiation Therapy
CIHR · 2022 · Co-investigator
$9,980
A phase III randomized controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) for Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer: SABR-COMET-3
CIHR · 2019 · Co-investigator
$699,380

All 2 grants and awards

21 publications.

Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.

Kooyman A, Chang JS, Liu M, Jiang W, Bergman A, Schellenberg D, Mou B, Alexander A, Carolan H, Hsu F, Miller S, Atrchian S, Chan E, Ho C, Mohamed I, Lin A, Berrang T, Bang A, Chng N, Matthews Q, Huang V, Mestrovic A, Hyde D, Lund C, Pai H, Valev B, Lefresne S, Tyldesley S, Olson R, Baker S

International journal of radiation oncology, biology, physics20262 citations

DOI: 10.1016/j.ijrobp.2025.03.079 PMID: 40216089

The role of abdominal compression in the reduction of respiratory motion for cardiac radioablation.

Marshall J, Bergman A, Karan T, Deyell MW, Schellenberg D, Thomas S

Journal of applied clinical medical physics2026Open Access

DOI: 10.1002/acm2.70561 PMID: 41904693

Multi-lead Monitoring to Deduce Translations and Rotations of the Heart Through Respiration and Its Geometric Implications for Motion Management in Cardiac Radioablation.

Marshall J, Karan T, Bergman A, Schellenberg D, Deyell MW, Thomas S

International journal of radiation oncology, biology, physics2026Open Access

DOI: 10.1016/j.ijrobp.2026.03.015 PMID: 41850495

The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.

Baker S, Leclerc C, Atmanspacher-Wirth H, Zhao Y, Schellenberg D, Clark H, Mou B, Liu M, Hsu F, Berrang T, Atrchian S, Bergman A, Chng N, Matthews Q, Chang JS, Tyldesley S, Olson R

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.01.031 PMID: 39923903

Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases.

Olson R, Liu M, Bergman A, Mou B, Abraham H, Leclerc C, Carolan H, Schellenberg D, Jiang W, Alexander A, Hsu F, Miller S, Atrchian S, Chan E, Ho C, Mohamed I, Lin A, Berrang T, Bang A, Gautam D, Chng N, Matthews Q, Huang V, Mestrovic A, Hyde D, Lund C, Pai H, Valev B, Lefresene S, Tyldesley S, Baker S

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111532 PMID: 42140754

Software Support Tools for Reirradiation: A Report From Reirradiation Collaborative Group (ReCOG) 2024.

Matrosic CK, Andrzejewski P, Bergman A, Chng N, Naqa IE, Freislederer P, Hoffmann L, Hope A, Jacqmin D, Kelly C, Kuo L, Lin H, Mayo C, Murrell DH, Ödén J, Svensson S, Thompson S, Osorio EV, West N, Wicha R, Yorke E, Appelt AL, Paradis KC

International journal of radiation oncology, biology, physics202518 citations

DOI: 10.1016/j.ijrobp.2024.12.023 PMID: 40240108

Toward the Use of Implanted Cardiac Leads or the Diaphragm for Active Respiratory Motion Management in Stereotactic Arrhythmia Radioablation.

Marshall J, Bergman A, Karan T, Deyell MW, Schellenberg D, Thomas S

International journal of radiation oncology, biology, physics20256 citationsOpen Access

DOI: 10.1016/j.ijrobp.2025.02.035 PMID: 40043856

Margins to account for cardiac and respiratory motion in cardiac radioablation.

Marshall J, Poon J, Bergman A, Karan T, Deyell MW, Schellenberg D, Thompson RB, Thomas S

Medical physics20253 citationsOpen Access

DOI: 10.1002/mp.70041 PMID: 41024249

Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.

Baker S, Lechner L, Liu M, Chang JS, Cruz-Lim EM, Mou B, Jiang W, Bergman A, Schellenberg D, Alexander A, Berrang T, Bang A, Chng N, Matthews Q, Carolan H, Hsu F, Miller S, Atrchian S, Chan E, Ho C, Mohamed I, Lin A, Huang V, Mestrovic A, Hyde D, Lund C, Pai H, Valev B, Lefresne S, Arbour G, Yu I, Tyldesley S, Olson RA

International journal of radiation oncology, biology, physics202415 citations

DOI: 10.1016/j.ijrobp.2024.01.008 PMID: 38220069

Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.

Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, Chng N, Bergman A, Mou B, Dunne EM, Schellenberg D, Jiang W, Chan E, Atrchian S, Lefresne S, Carolan H, Valev B, Tyldesley S, Bang A, Berrang T, Clark H, Hsu F, Louie AV, Warner A, Palma DA, Howell D, Barry A, Dawson L, Grendarova P, Walker D, Sinha R, Tsai J, Bahig H, Thibault I, Koul R, Senthi S, Phillips I, Grose D, Kelly P, Armstrong J, McDermott R, Johnstone C, Vasan S, Aherne N, Harrow S, Liu M

BMC cancer20242 citationsOpen Access

DOI: 10.1186/s12885-024-11905-7 PMID: 38310262

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Alanah Bergman

Research

Latest papers

Latest funding

Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.

The role of abdominal compression in the reduction of respiratory motion for cardiac radioablation.

Multi-lead Monitoring to Deduce Translations and Rotations of the Heart Through Respiration and Its Geometric Implications for Motion Management in Cardiac Radioablation.

The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.

Five-year follow-up of the SABR-5 trial: primary toxicity analysis of stereotactic ablative radiotherapy for up to five oligometastases.

Software Support Tools for Reirradiation: A Report From Reirradiation Collaborative Group (ReCOG) 2024.

Toward the Use of Implanted Cardiac Leads or the Diaphragm for Active Respiratory Motion Management in Stereotactic Arrhythmia Radioablation.

Margins to account for cardiac and respiratory motion in cardiac radioablation.

Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.

Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.

Future of Stereotactic Ablative Radiotherapy (SABR) Trials in Oligometastatic Cancer: Continuing Canadian-Led International Investigations in Radiation Therapy

A phase III randomized controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) for Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer: SABR-COMET-3

Frequent collaborators

Devin Schellenberg

Robert Olson

Scott Tyldesley

Dr. Olson

Steven Thomas

David Palma

Alan Nichol

Marc Deyell

Cheryl Duzenli

Ermias Gete

Michael Mckenzie

Andrew Hope

Arjun Sahgal

Houda Bahig

Laura Dawson

Donna Murrell

Isabelle Thibault

Wayne Beckham

Isabelle Gagne

Chris Thomas

Issam El Naqa

Richard Thompson

Stewart Gaede

Michael Peacock